These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21850920)

  • 1. Do drospirenone-containing oral contraceptives have a higher risk of VTE?
    Ribowsky JH
    JAAPA; 2011 Aug; 24(8):51-3. PubMed ID: 21850920
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
    Heinemann K; Heinemann LA
    J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
    [No Abstract]   [Full Text] [Related]  

  • 4. Another flawed database study.
    Szarewski A; Mansour D; Shapiro S
    Contraception; 2013 Apr; 87(4):505-6. PubMed ID: 23261232
    [No Abstract]   [Full Text] [Related]  

  • 5. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2012 Nov; 120(5):1239-42. PubMed ID: 23090561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drospirenone and VTE.
    Leppée M; Eric M; Culig J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
    BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in adolescents associated with drospirenone-containing oral contraceptives - two case reports.
    Toni I; Neubert A; Botzenhardt S; Gratzki N; Rascher W
    Klin Padiatr; 2013 Sep; 225(5):266-7. PubMed ID: 23975850
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of blood clots higher for oral contraceptives with certain progestins.
    Voelker R
    JAMA; 2011 Nov; 306(20):2206. PubMed ID: 22110099
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
    Dinger J; Möhner S; Heinemann K
    Contraception; 2016 May; 93(5):378-85. PubMed ID: 26825258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    Bird ST; Delaney JA; Etminan M; Brophy JM; Hartzema AG
    J Thromb Haemost; 2013 Jun; 11(6):1059-68. PubMed ID: 23574590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
    Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
    Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
    Botzenhardt S; Toni I; Rascher W; Neubert A
    Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hormonal contraception and venous thromboembolism (VTE).
    Reid RL
    Contraception; 2014 Apr; 89(4):235-6. PubMed ID: 24594431
    [No Abstract]   [Full Text] [Related]  

  • 17. Drospirenone Litigation: Does the Punishment Fit the Crime?
    Batur P; Casey PM
    J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial.
    Nisenbaum MG; de Melo NR; Giribela CR; de Morais TL; Guerra GM; de Angelis K; Mostarda C; Baracat EC; Consolim-Colombo FM
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():62-6. PubMed ID: 24480113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debating the evidence: oral contraceptives containing drospirenone and risk of blood clots.
    Dodd S
    Curr Drug Saf; 2011 Jul; 6(3):132-3. PubMed ID: 22122386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.